|
Volumn 52, Issue 2, 2019, Pages 365-366
|
Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient
|
Author keywords
Coinfection; Influenza A(H1N1)pdm09; Pneumonia; Pseudomonas aeruginosa
|
Indexed keywords
AMIKACIN;
AZTREONAM;
CEFEPIME;
CEFTAZIDIME;
CIPROFLOXACIN;
GENTAMICIN;
IMIPENEM;
LEVOFLOXACIN;
MEROPENEM;
OSELTAMIVIR;
PIPERACILLIN PLUS TAZOBACTAM;
ADULT;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
ANTIVIRAL THERAPY;
ARTIFICIAL VENTILATION;
BLOOD PRESSURE;
BODY TEMPERATURE;
BREATHING RATE;
CASE REPORT;
CLINICAL ARTICLE;
COMMUNITY ACQUIRED PNEUMONIA;
COMPUTER ASSISTED TOMOGRAPHY;
DYSPNEA;
ENDOTRACHEAL INTUBATION;
EXTRACORPOREAL OXYGENATION;
FATALITY;
FEMALE;
HEART RATE;
HUMAN;
INFLUENZA A (H1N1);
INTENSIVE CARE;
LETTER;
LEUKOCYTE COUNT;
LYMPHOCYTE COUNT;
MIXED INFECTION;
MONOCYTE COUNT;
NEUTROPHIL COUNT;
NONHUMAN;
OXYGEN BREATHING;
PHAGOCYTE;
POLYMERASE CHAIN REACTION;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTION;
SHOCK;
SPUTUM CULTURE;
WORLD HEALTH ORGANIZATION;
COMMUNITY ACQUIRED INFECTION;
DIAGNOSTIC IMAGING;
DRUG EFFECT;
INFLUENZA;
INFLUENZA A VIRUS (H1N1);
MICROBIAL SENSITIVITY TEST;
MICROBIOLOGY;
PATHOGENICITY;
PATHOLOGY;
PNEUMONIA;
THORAX;
VIROLOGY;
ADULT;
COINFECTION;
COMMUNITY-ACQUIRED INFECTIONS;
FATAL OUTCOME;
FEMALE;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
MICROBIAL SENSITIVITY TESTS;
PNEUMONIA;
PSEUDOMONAS AERUGINOSA;
THORAX;
|
EID: 85063743120
PISSN: 16841182
EISSN: 19959133
Source Type: Journal
DOI: 10.1016/j.jmii.2018.05.007 Document Type: Letter |
Times cited : (30)
|
References (5)
|